Marc Iskowitz

Most recent articles by Marc Iskowitz

Former Baxter exec Giuseppe Accogli accepts group CEO post at Chiesi
Former Baxter exec Giuseppe Accogli accepts group CEO post at Chiesi
Marc Iskowitz
January 30, 2023
11:33 am

Accogli is set to join effective April 3 following an international search to replace former CEO Ugo Di Francesco.

‘Known unknowns’ make new pricing law a wild card for drug companies
‘Known unknowns’ make new pricing law a wild card for drug companies
Marc Iskowitz
January 30, 2023
5:30 am

The Inflation Reduction Act is the drug industry’s new talking point. Companies are raising awareness of the law’s unintended consequences, while reassuring investors that they can manage through the risk.

Who’s afraid of ChatGPT? AI in healthcare could save $360B
Who’s afraid of ChatGPT? AI in healthcare could save $360B
Marc Iskowitz
January 24, 2023
4:03 pm

A study claims AI could have an outsized financial and non-financial impact in healthcare. The next few years will determine whether the promise becomes reality.

Takeda plunks down $400M for ex-China rights to Hutchmed cancer drug
Takeda plunks down $400M for ex-China rights to Hutchmed cancer drug
Marc Iskowitz
January 23, 2023
12:15 pm

The Takeda deal terms also include up to $730 million in potential milestone and royalty payments.

Fishawack Health hires Elly Price as managing director
Fishawack Health hires Elly Price as managing director
Marc Iskowitz
January 20, 2023
12:00 pm

Price brings more than 25 years of experience in pharmaceutical marketing.

FDA spikes accelerated-approval request for Lilly Alzheimer’s drug
FDA spikes accelerated-approval request for Lilly Alzheimer’s drug
Marc Iskowitz
January 20, 2023
11:15 am

The rejection could push back a potential commercial launch by several months, provided regulators move to approve it.

‘We’re still here’: U.S., global drug markets show robust recovery
‘We’re still here’: U.S., global drug markets show robust recovery
Marc Iskowitz
January 20, 2023
5:30 am

Despite questions confronting the drug trend at the tail end of the pandemic, spending on medicines has shown a ‘remarkable resilience.’

‘Outdated notions’ holding back use of effective obesity drugs: report
‘Outdated notions’ holding back use of effective obesity drugs: report
Marc Iskowitz
January 18, 2023
9:10 am

Medical practice and clinical evidence must ‘realign’ in order to combat the epidemic, a patient safety group argues.

Wunderman Thompson Health taps Area 23’s Renata Maia as global CCO 
Wunderman Thompson Health taps Area 23’s Renata Maia as global CCO 
Marc Iskowitz
January 17, 2023
1:07 pm

Maia looks to bring a ‘fearless’ creative approach to the agency.

GLP-1 wars, an Alzheimer’s credibility deficit and other observations from JPM
GLP-1 wars, an Alzheimer’s credibility deficit and other observations from JPM
Marc Iskowitz
January 13, 2023
5:30 am

A few biopharma trends we’re tracking as the 41st annual JP Morgan Healthcare Conference comes to a close.

  • From Our Partners